Why We Built the National Peptide Registry

The Peptide Landscape Is Broken

If you’ve ever tried to research a peptide online, you know the feeling. One site promises miraculous results. Another warns of catastrophic side effects. A Reddit thread swears by a protocol with zero citations. A TikTok influencer holds up a vial and tells you to “trust the process.”

The truth is, peptide therapeutics represent one of the most exciting frontiers in modern medicine — but the information landscape surrounding them is a mess. Conflicting claims, aggressive marketing, regulatory gray zones, and a near-total absence of centralized, objective data have created an environment where even well-informed patients and clinicians struggle to separate signal from noise.

Why We Decided to Act

We built the National Peptide Registry because we believe everyone deserves access to reliable, unbiased peptide data — not just those with the scientific training to parse clinical trials, or the financial resources to consult specialized practitioners.

The idea started simply: what if there were a single place where you could look up any peptide and find its FDA status, a plain-language summary of the research, known safety considerations, and real-world patient experiences — all in one place, with no sales pitch attached?

That question became the NPR.

What Makes Us Different

We are not a clinic, a pharmacy, or a supplement company. We don’t sell peptides. We don’t accept advertising from peptide vendors. We have no financial incentive to tell you that any particular compound is safe, effective, or worth your money.

Instead, we focus on three things:

• Aggregating clinical research — translating dense academic papers into accessible, accurate summaries that anyone can understand.
• Tracking regulatory status — monitoring FDA actions, compounding pharmacy rules, and international regulations in real time so our data is always current.
• Collecting real-world data — securely crowdsourcing patient experiences to build the kind of evidence base that clinical trials alone cannot provide.

We already have over 20 peptide profiles live on the registry, each one built from the ground up with citations, regulatory context, and safety data.

Your Experience Matters

The most powerful part of the NPR isn’t anything we built — it’s the community contributing to it. Every data point from a real person using a real peptide adds to our collective understanding. Patterns emerge. Safety signals surface. Knowledge compounds.

Whether you’re a researcher studying peptide mechanisms, a clinician navigating prescribing decisions, or a patient trying to make sense of your own experience — your perspective has value here.

If you’ve ever used a peptide, researched one, or are simply curious — join the registry. Your experience matters.